History
  • No items yet
midpage
Copley v. Bactolac Pharmaceutical, Inc.
2:18-cv-00575
E.D.N.Y
Mar 10, 2021
Read the full case

Background

  • Plaintiffs from multiple states allege they were harmed by consuming "All Day Energy Greens" (ADEG), a dietary supplement marketed by NaturMed and manufactured/packaged by Bactolac under contract.
  • Plaintiffs contend Bactolac substituted cheaper/inferior ingredients, causing illness and death; NaturMed voluntarily recalled ADEG in 2016.
  • Plaintiffs sued NaturMed, alleged successor Independent Vital Life, LLC, and Bactolac under multiple state consumer-protection, warranty, tort, and unjust enrichment theories and the federal Magnuson–Moss Warranty Act.
  • Bactolac moved to dismiss certain claims (Rule 12(b)(6)), to strike punitive damages, and moved for judgment on the pleadings as to NaturMed’s cross-claims (Rule 12(c)).
  • The parties narrowed issues by plaintiffs’ withdrawal of several claims; the Court focused on eight contested plaintiff claims and NaturMed’s cross-claims.
  • There was related Arizona litigation: Bactolac sued NaturMed in 2016; NaturMed voluntarily dismissed some counterclaims without prejudice and did not oppose Bactolac’s later summary-judgment motion, which the Arizona court granted.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Magnuson–Moss Warranty Act (Claim I) Federal warranty claim based on state warranty violations. Federal claim depends on survival of state warranty claims. Survives because Bactolac did not move to dismiss all underlying state warranty claims.
N.Y. GBL § 349 (Claim III) § 349 applies because Bactolac is headquartered in New York. Deception/transaction did not occur in NY; § 349 targets consumer-oriented conduct. Dismissed: plaintiffs had no NY consumer transaction or deception.
Ala. Deceptive Trade Practices Act (Claim V) Pressley discovered injury 2014 and recall 2016; claim timely under discovery rule. One-year statute of limitations bars claim. Not barred as a matter of law; discovery/notice is for the jury.
Cal. Bus. & Prof. Code § 17500 (Claim IX) Label affixed by Bactolac is an advertising device. Bactolac merely affixed labels produced/marketed by NaturMed; not advertising by Bactolac. Dismissed: affixing another party’s label does not reasonably constitute advertising.
Mo. implied warranty (Claim XIX) Remote purchaser may sue manufacturer for implied warranty. Plaintiff failed to give required notice to seller. Dismissed for failure to plead notice.
Va. Consumer Protection Act (Claim XXIX) VCPA covers supplier liability even without direct sale to consumer. Bactolac is not a "supplier" under statute—it manufactured under contract and did not sell to consumers. Dismissed: Bactolac not within statutory definition of supplier here.
Wis. Deceptive Trade Practices Act (Claim XXXII) ADEG representations were deceptive to the public. No allegation Bactolac advertised or made public representations. Dismissed: complaint lacks public-facing advertising by Bactolac.
Unjust Enrichment (Claim XXXVI) Plaintiffs conferred benefit by purchasing ADEG; Bactolac unjustly benefited. Payments were made to NaturMed; any indirect benefit to Bactolac insufficient. Dismissed: benefit was not specific and direct to Bactolac.
Punitive damages (motion to strike) Allegations of substitution, continued use after reports, and concealment support punitive damages. Punitive damages standard under NY law not met. Denied: complaint sufficiently pleads facts that could support punitive damages.
NaturMed cross-claims preclusion (fraud, negligence, contract/warranty) NaturMed: earlier Arizona dismissals were without prejudice or premature; some claims had not yet accrued. Bactolac: Arizona summary judgment and compulsory-counterclaim principles preclude NaturMed’s cross-claims. Judgment on pleadings granted as to fraud and negligence (barred); denied as to breach of contract, express and implied warranty, and indemnity (these proceed).

Key Cases Cited

  • Clemens v. DaimlerChrysler Corp., 534 F.3d 1017 (9th Cir. 2008) (Magnuson–Moss claims rise or fall with underlying state warranty claims)
  • Goshen v. Mutual Life Ins. Co. of N.Y., 98 N.Y.2d 314 (2002) (§ 349 requires deception/transaction occurring in New York)
  • Cruz v. FXDirectDealer, LLC, 720 F.3d 115 (2d Cir. 2013) (interpreting two lines of § 349 decisions regarding where deception/transaction must occur)
  • Oswego Laborers’ Local 214 Pension Fund v. Marine Midland Bank, N.A., 85 N.Y.2d 20 (1995) (§ 349 targets consumer-oriented, public-facing wrongs)
  • Ross v. Louise Wise Servs., Inc., 8 N.Y.3d 478 (2007) (standards for punitive damages under New York law)
  • Prozeralik v. Capital Cities Commc’ns, Inc., 82 N.Y.2d 466 (1993) (punitive damages require aggravating or outrageous conduct)
  • Kaye v. Grossman, 202 F.3d 611 (2d Cir. 2000) (unjust enrichment requires a specific and direct benefit)
  • Lansford v. Harris, 850 P.2d 126 (Ariz. 1992) (compulsory counterclaim rule and claim preclusion)
  • Airfreight Exp. Ltd. v. Evergreen Air Ctr., Inc., 158 P.3d 232 (Ariz. Ct. App. 2007) (dismissal without prejudice is not an adjudication on the merits)
  • Chaney Bldg. Co. v. City of Tucson, 716 P.2d 28 (1986) (issue preclusion requires the issue to have been actually litigated)
Read the full case

Case Details

Case Name: Copley v. Bactolac Pharmaceutical, Inc.
Court Name: District Court, E.D. New York
Date Published: Mar 10, 2021
Docket Number: 2:18-cv-00575
Court Abbreviation: E.D.N.Y